Biogened S.A. (WSE:BGD)
19.50
+0.10 (0.52%)
At close: Apr 28, 2026
Biogened Market Cap
Biogened has a market cap or net worth of 47.90 million as of April 29, 2026. Its market cap has decreased by -25.00% in one year.
Market Cap
47.90M
Enterprise Value
65.82M
Revenue
114.04M
Ranking
n/a
PE Ratio
10.36
Stock Price
19.50
Market Cap Chart
Since August 31, 2011, Biogened's market cap has increased from 45.77M to 47.90M, an increase of 4.66%. That is a compound annual growth rate of 0.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MakoLab Spólka Akcyjna | 48.21M |
| Prymus | 48.00M |
| Telestrada | 48.29M |
| ORGANIC Farma Zdrowia | 47.88M |
| BioMaxima | 48.98M |
| CDRL S.A. | 49.00M |
| V-Max Spolka Akcyjna | 47.12M |
| Caspar Asset Management | 49.31M |